Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Osteopontin: An emerging therapeutic target for anticancer therapy
Shalini Jain
,
Goutam Chakraborty
, Anuradha Bulbule
, Rajinder Kaur
, Gopal C. Kundu
Research output
:
Contribution to journal
›
Review article
›
peer-review
48
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Osteopontin: An emerging therapeutic target for anticancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Therapeutic Target
100%
Anticancer Therapy
100%
Emerging Therapeutics
100%
Osteopontin
100%
Tumor Progression
28%
Cancer Treatment
28%
Metastasis
28%
Molecular Mechanism
14%
Family Members
14%
Signaling Cascades
14%
Malignant Cells
14%
Tumorigenesis
14%
Therapeutic Strategies
14%
Cancer Progression
14%
Signaling Pathway
14%
Prognostic Marker
14%
Successful Treatment
14%
Novel Anticancer Therapies
14%
Integrin Binding
14%
N-glycoproteins
14%
Binding Ligand
14%
Biochemistry, Genetics and Molecular Biology
Anticancer
100%
Osteopontin
100%
Carcinogenesis
28%
Tumor Progression
28%
Glycoprotein
14%
Ligand Binding
14%
Integrin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Osteopontin
100%
Malignant Neoplasm
42%
Tumor Growth
28%
Carcinogenesis
28%
Cancer Growth
14%
Glycoprotein
14%
Integrin
14%
Diseases
14%